Researcher
Thomas Vanassche
- Disciplines:Cardiac and vascular medicine, Molecular and cell biology
Affiliations
- Centre for Molecular and Vascular Biology (Division)
Member
From19 Aug 2010 → Today - Cardiology (Division)
Member
From1 Oct 2009 → 18 Aug 2010
Projects
1 - 10 of 13
- Multigene thrombophilia testing in patients with venous thromboembolismFrom1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Development, Validation, and Valorization of a Patient Preference Platform to Inform Healthcare Decision-MakingFrom1 Mar 2023 → TodayFunding: IOF - technology validation in lab
- Mechanical cardiac unloading with micro-axial flow pumps: post-implantation effects on remodelling and bleeding/thrombosisFrom16 Sep 2021 → TodayFunding: FWO fellowships
- Targeting Immunothrombosis in Staphylococcus Aureus Infections and EndocarditisFrom1 Jan 2021 → TodayFunding: FWO research project (including WEAVE projects)
- Investigating the role of neutrophil extracellular traps in the failing heartFrom1 Oct 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Targeting Immunothrombosis in Staphylococcus aureus infections and endocarditisFrom1 Oct 2020 → TodayFunding: BOF - projects
- Calming the storm: treating hypercoagulability and hyperinflammation in patients with COVID-19From22 May 2020 → 21 May 2021Funding: FWO thematic call for applied research
- Neutrophil extracellular traps in cardiac fibrosis - Peptidylarginine deiminase 4 and neutrophil extracellular traps in chronic inflammation and cardiac fibrosisFrom1 Oct 2019 → 6 Oct 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Thromboinflammation in Cardiovascular DiseasesFrom1 Aug 2019 → 20 Dec 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Activation of the contact pathway of coagulation in cardiovascular diseasesFrom1 Oct 2017 → 30 Sep 2019Funding: BOF - Other initiatives
Publications
41 - 50 of 176
- THE ASSOCIATION OF URINARY MATRIX GLA PROTEIN WITH CIRCULATING INACTIVE MATRIX GLA PROTEIN, RENAL FUNCTION AND MORTALITY RISK: A POPULATION STUDY(2022)
Authors: Dongmei Wei, Thomas Vanassche, Lucas Van Aelst, Peter Verhamme
Pages: E123 - E123 - Mechanical properties and cellular content of leukocyte- and platelet-rich fibrin membranes of patients on antithrombotic drugs(2022)
Authors: Heleen Fehervary, Peter Verhamme, Constantinus Politis, Thomas Vanassche, Annabel Braem, Marc Quirynen, Reinhilde Jacobs
Pages: 623 - 631 - Improving appropriate use of anticoagulants in hospitalised patients: a pharmacist-led Check of Medication Appropriateness intervention.(2022)
Authors: Charlotte Quintens, Peter Verhamme, Thomas Vanassche, Christophe Vandenbriele, Bart Van den Bosch, Lorenz Van der Linden, Isabel Spriet
Pages: 2959 - 2968 - Anticoagulation for Percutaneous Ventricular Assist Device-Supported Cardiogenic Shock JACC Review Topic of the Week(2022)
Authors: Christophe Vandenbriele, Bart Meyns, Thomas Vanassche
Pages: 1949 - 1962 - Prevalence of Acute Pulmonary Embolism at Autopsy in Patients With COVID-19(2022)
Authors: Thomas Vanassche, Peter Verhamme, Christophe Vandenbriele
Pages: 159 - 164 - Estimating Bleeding Risk in Patients with Cancer-Associated Thrombosis: Evaluation of Existing Risk Scores and Development of a New Risk Score(2022)
Authors: Thomas Vanassche
Pages: 818 - 829 - Urinary Proteomic Profile of Arterial Stiffness Is Associated With Mortality and Cardiovascular Outcomes(2022)
Authors: Dongmei Wei, Jesus Melgarejo, Thomas Vanassche, Lucas Van Aelst, Jan A Staessen, Peter Verhamme, Zhenyu Zhang
- The novel proteomic signature for cardiac allograft vasculopathy(2022)
Authors: Dongmei Wei, Sander Trenson, Jan Van Keer, Jesus Melgarejo, Thomas Vanassche, Lucas Van Aelst, Jan A Staessen, Peter Verhamme, Zhenyu Zhang
Pages: 1216 - 1227 - Belgian clinical guidance on anticoagulation management in hospitalised and ambulatory patients with COVID-19(2022)
Authors: Thomas Vanassche, Christophe Vandenbriele, Peter Verhamme
Pages: 280 - 285 - Thromboprophylaxis in COVID-19: Weight and severity adjusted intensified dosing(2022)
Authors: Christophe Vandenbriele, Caroline Martens, Bert Vandenberk, Pieter Sinonquel, Natalie Lorent, Paul De Munter, Rik Willems, Joost Wauters, Alexander Wilmer, Dieter Dauwe, et al.